TOP OF THE NEWS
SACGHS issues final report
Myriad expands direct-to-consumer marketing
REGULATORY/GOVERNMENT NEWS
FDA clears third warfarin genotyping test
Congress passes GINA bill
Part B lab spending climbs to $6.8 billion
SCIENCE/TECHNOLOGY
Genzyme launches SMA testing
Group B strep increases in adults
NEJM study finds genetic links to neuroblastoma
Saliva-based cardiac diagnosis on a chip
BUSINESS NEWS
Inverness closes Matria Healthcare deal
LabCorp expands companion diagnostics focus
Beckman Coulter licenses Siemens HCV test
Enzo Biochem buys Biomol
INSIDE DIAGNOSTICS INDUSTRY
SACGHS report calls for expanded regulation, resources for genetic testing
FINANCIAL NEWS
IVD stocks down 4%
G-2 INSIDER
Outreach testing by the numbers

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2008 - Table of Contents

DTTR June 2008 (full PDF issue)

SACGHS Report Calls for Expanded FDA Oversight

Myriad Genetics to Expand Direct-to-Consumer Marketing Efforts

FDA Clears Third Warfarin Genotyping Test

Congress Passes Ban on Genetic Discrimination, Measure Ready for Signing

Genzyme Genetics Launches Testing for Spinal Muscular Atrophy

Inverness Completes Acquisition of Matria Healthcare

SACGHS Calls for Expanded Regulation, Resources for Genetic Testing

Part B Lab Spending Climbs to $6.8 Billion in 2007

LabCorp Expands Companion Diagnostic Development Focus

Beckman Coulter Licenses HCV Test from Siemens

Group B Strep Increases Among Adults

NEJM Study Finds Genetic Links to Neuroblastoma

Saliva-Based Method Shows Promise for Early Diagnosis of Heart Attack

Enzo Biochem Buys Biomol to Boost Life Sciences Business

IVD Stocks Lose 4%; Affymetrix Drops 34%

Outreach Testing by the Numbers